Medicare Enrolled
Dr. Hwan Jeong, M.D.
Hematology & Oncology · Normal, IL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Jeong from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Jeong?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Jeong
Dr. Hwan Jeong is a hematology & oncology specialist in Normal, IL, with 21 years of NPI registration. Based on federal Medicare data, Dr. Jeong performed 134,660 Medicare services across 3,355 unique beneficiaries.
Between the years covered by Open Payments, Dr. Jeong received a total of $7,265 from 42 pharmaceutical and/or device companies across 335 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Jeong is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 21 years in practice
▲ Top 9% volume in IL
$7,265 industry payments
Medicare Practice Summary
Medicare Utilization ↗134,660
Medicare services
Top 9% in IL for hematology & oncology
3,355
Unique beneficiaries
$5
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~6,412 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Injectafer) An intravenous injection of ferric carboxymaltose, an iron replacement medication. |
97,500 | $1 | $2 |
| Epoetin alfa injection (Retacrit) for anemia An injection of a biosimilar form of epoetin alfa used for non-end-stage renal disease purposes. The dose administered is 1000 units. |
11,680 | $6 | $20 |
| Denosumab injection (Prolia/Xgeva) | 4,560 | $18 | $30 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
3,710 | $0 | $1 |
| Anti-nausea injection (Aloxi/palonosetron) | 2,210 | $1 | $35 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
1,750 | $8 | $45 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
1,643 | $8 | $20 |
| Injection, granisetron hydrochloride, 100 mcg | 1,540 | $0 | $4 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,315 | $94 | $250 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
1,175 | $10 | $55 |
| Pegfilgrastim-cbqv injection An injection of pegfilgrastim-cbqv, a biosimilar medication, administered at a dose of 0.5 mg. |
972 | $109 | $500 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
955 | $12 | $140 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
634 | $11 | $80 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
417 | $97 | $440 |
| Lactate dehydrogenase (LDH) level test A blood test that measures the amount of lactate dehydrogenase, an enzyme found in many body tissues. It helps assess tissue damage or disease. |
382 | $6 | $30 |
| Ferritin level test (iron stores) A blood test that measures the level of ferritin, a protein that stores iron in the body. |
333 | $13 | $50 |
| Reticulated platelet measurement A blood test that measures the level of young, newly formed platelets in the body. |
324 | $35 | $59 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
276 | $21 | $190 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
259 | $47 | $242 |
| Immunoglobulin level test A blood test that measures the level of gammaglobulins, which are immune system proteins. |
253 | $9 | $30 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
196 | $1 | $4 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
169 | $15 | $139 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
169 | $64 | $175 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
149 | $48 | $220 |
| Thyroid stimulating hormone (TSH) test A blood test that measures the level of thyroid stimulating hormone to evaluate thyroid function. |
128 | $16 | $60 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
119 | $1 | $6 |
| Free thyroxine (T4) test A blood test that measures the level of free thyroxine, a thyroid hormone, in the bloodstream. |
115 | $9 | $30 |
| Direct bilirubin level test A blood test that measures the amount of direct bilirubin in your body. Direct bilirubin is the form of the waste product processed by the liver. |
113 | $5 | $30 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
109 | $10 | $220 |
| Iron level test | 106 | $6 | $40 |
| Complete blood count (CBC), automated An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood. |
105 | $6 | $25 |
| Iron binding capacity test A blood test that measures the amount of iron in the blood and the blood's ability to bind and transport iron. |
102 | $9 | $40 |
| Manual white blood cell count A laboratory test that involves examining a sample under a microscope to manually count the number of white blood cells present. |
98 | $4 | $30 |
| Normal saline infusion, 500 ml Administration of sterile normal saline solution through an intravenous line. This procedure involves the infusion of a 500 ml unit of the solution. |
88 | $1 | $20 |
| Carcinoembryonic antigen (CEA) level test A blood test that measures the level of carcinoembryonic antigen (CEA) protein. This test is used to monitor certain types of cancer. |
87 | $18 | $55 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
87 | $1 | $20 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
81 | $22 | $210 |
| Normal saline infusion, 250 cc Administration of 250 cubic centimeters of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater fluid. |
81 | $1 | $20 |
| Midazolam injection, per 1 mg Administration of midazolam hydrochloride, a sedative medication, measured in 1 mg increments. |
74 | $0 | $10 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
61 | $18 | $60 |
| Immunologic analysis for detection of tumor antigen, quantitative; ca 125 | 59 | $20 | $75 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
59 | $2 | $20 |
| Additional sedation, per 15 minutes Administration of a drug to deepen sedation during a procedure. This code covers each additional 15-minute increment of sedation beyond the initial period. |
53 | $8 | $100 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
50 | $111 | $410 |
| Magnesium level test A blood test to measure the amount of magnesium in your body. This helps check for magnesium deficiency or excess. |
49 | $7 | $25 |
| Intravenous drug injection A procedure involving the administration of a medication or substance directly into a vein. |
49 | $28 | $210 |
| PSA test (prostate cancer screening) | 29 | $18 | $50 |
| Injection, hydrocortisone sodium succinate, up to 100 mg | 29 | $13 | $25 |
| Bone marrow biopsy and aspiration A procedure to remove a small sample of bone marrow and liquid for laboratory testing. The sample is analyzed to help diagnose various medical conditions. |
27 | $134 | $600 |
| Sedation by physician, initial 15 minutes Administration of a drug to induce depression of consciousness by the physician performing a procedure. This code covers the initial 15 minutes of sedation for patients aged 5 years or older. |
27 | $38 | $150 |
| Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 | 25 | $20 | $60 |
| Injection, fentanyl citrate, 0.1 mg | 25 | $1 | $10 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
24 | $63 | $200 |
| Automated red blood cell count with calculations A blood test that automatically counts red blood cells and performs additional calculations to assess blood health. |
17 | $5 | $15 |
| Vitamin D level test A blood test to measure the amount of Vitamin D-3 in your body. |
13 | $29 | $60 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
73.4% high complexity
20.0% medium
6.6% routine
Industry Payment Transparency
Open Payments through 2024 ↗$7,265
Total received (2018-2024)
Avg $1,038/year across 7 years
Top 34% in IL for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
42
Companies
335
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,298 (72.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$1,200 (16.5%)
Other
Charitable contributions, space rental, and other categories
$767 (10.6%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,152
2023
$1,786
2022
$1,929
2021
$864
2020
$224
2019
$291
2018
$20
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$767
Genentech USA, Inc.
$235
Janssen Biotech, Inc.
$157
Daiichi Sankyo Inc.
$148
Lilly USA, LLC
$121
BeiGene USA, Inc.
$97
PFIZER INC.
$71
AstraZeneca Pharmaceuticals LP
$69
GENZYME CORPORATION
$68
Merck Sharp & Dohme LLC
$63
Astellas Pharma US Inc
$60
Gilead Sciences, Inc.
$44
ABBVIE INC.
$43
Exelixis Inc.
$36
SpringWorks Therapeutics, Inc.
$32
Eisai Inc.
$28
Blueprint Medicines Corporation
$23
ADC Therapeutics America, Inc.
$23
Genmab U.S., Inc.
$21
Incyte Corporation
$19
Fennec Pharmaceuticals, Inc.
$15
TAIHO ONCOLOGY, INC.
$14
Top 3 companies account for 53.8% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$1,144
Genentech USA, Inc.
$1,052
Janssen Biotech, Inc.
$713
Merck Sharp & Dohme LLC
$428
ABBVIE INC.
$406
Astellas Pharma US Inc
$331
AstraZeneca Pharmaceuticals LP
$301
Daiichi Sankyo Inc.
$277
Lilly USA, LLC
$271
PFIZER INC.
$243
E.R. Squibb & Sons, L.L.C.
$207
Celgene Corporation
$200
GENZYME CORPORATION
$196
BeiGene USA, Inc.
$156
Amgen Inc.
$142
Incyte Corporation
$104
Seagen Inc.
$84
Eisai Inc.
$74
Karyopharm Therapeutics Inc.
$73
ADC Therapeutics America, Inc.
$63
ARRAY BIOPHARMA INC
$62
Gilead Sciences, Inc.
$60
Regeneron Healthcare Solutions, Inc.
$56
AVEO Pharmaceuticals, Inc.
$54
GlaxoSmithKline, LLC.
$54
TAIHO ONCOLOGY, INC.
$49
Janssen Pharmaceuticals, Inc
$49
JAZZ PHARMACEUTICALS INC.
$44
AbbVie Inc.
$43
Genmab U.S., Inc.
$42
Mirati Therapeutics, Inc.
$37
Exelixis Inc.
$36
Foundation Medicine, Inc.
$32
SpringWorks Therapeutics, Inc.
$32
Pharmacosmos Therapeutics Inc.
$24
Blueprint Medicines Corporation
$23
Pharmacyclics LLC, an AbbVie Company
$22
AbbVie, Inc.
$20
EISAI INC.
$18
Ipsen Biopharmaceuticals, Inc
$16
Fennec Pharmaceuticals, Inc.
$15
Rigel Pharmaceuticals, Inc.
$12
Top 3 companies account for 40.0% of all-time payments
Associated products mentioned in payments ›
ADAKVEO · ADCETRIS · AYVAKIT · Alecensa · BOSULIF · BRAFTOVI · BRUKINSA · CABLIVI · CABOMETYX · CYRAMZA · Columvi · Creon · DARZALEX · ELIQUIS · ELITEK · EMPLICITI · ENHERTU · ENJAYMO · EPKINLY · ERLEADA · Enhertu · Epkinly · FOTIVDA · FOUNDATIONONE · Fabhalta · GAZYVA · IBRANCE · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · JAKAFI · JEVTANA · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LONSURF · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lunsumio · MEKTOVI · MONJUVI · Monoferric · Nplate · OGSIVEO · OJJAARA · ONUREG · OPDIVO · PADCEV · PROMACTA · Padcev · Pedmark · Perjeta · Polivy · Pomalyst · REBLOZYL · SARCLISA · SCEMBLIX · SOMATULINE DEPOT · SPRYCEL · TASIGNA · TECVAYLI · TIVDAK · Tavalisse · Trodelvy · VENCLEXTA · VERZENIO · Vyloy · XARELTO · XPOVIO · XTANDI · Xospata · Xtandi · ZEJULA · ZEPZELCA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (73%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Hematology & oncology specialists within 10 mi
1
Per 100K population
0.6
County median income
$78,329
Nearest hospital
CARLE BROMENN MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Jeong is a mixed practice specialist, with above-average Medicare volume (top 9% in IL), with low-engagement industry engagement, with 21 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Jeong experienced with iron infusion (injectafer)?
Based on Medicare claims data, Dr. Jeong performed 97,500 iron infusion (injectafer) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Jeong receive payments from pharmaceutical companies?
Yes. Dr. Jeong received a total of $7,265 from 42 companies across 335 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Jeong's costs compare to other hematology & oncology specialists in Normal?
Dr. Jeong's average Medicare payment per service is $5. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Jeong) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Normal
Browse hematology & oncology specialists in Normal ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in IL
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in IL
Which IL hematology & oncology specialists receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Genentech USA, Inc. Payments to Doctors
See all physicians who received payments from Genentech USA, Inc.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology